Fact CheckerSign in

NCT06708000Enrolling by invitationPhase 3

Personalized Evaluation of Susptected Myocardial Ischemia

Personalized Evaluation of Suspected Myocardial Ischemia

Source: ClinicalTrials.gov · Last updated 19 Dec 2025

Brief summary (registry, in English)

This study aims to assess whether the use of clinical risk models, known as Clinical Likelihood (CL) models, can reduce the need for diagnostic examinations without negatively impacting quality of life or prognosis after 12 months in patients with stable new onset chest pain. Additionally, the project will evaluate a newly developed method called Laser Speckle Contrast Imaging for measuring function and oxygen content in the smallest blood vessels (microvasculature) of the hand, which may also reflect blood flow and oxygen content in the microvasculature of the heart.

Status (registry)
Enrolling by invitation
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
2000 (estimated)
First submitted
13 Nov 2024
Start date
20 Nov 2024
Primary completion date
31 Dec 2027
Lead sponsor
Gødstrup Hospital
NCT number
NCT06708000

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 2000
  • From 20 Nov 2024 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Known ischemic heart disease, including previous PCI (with or without stent) and bypass surgery

Other illness

  • Unstable angina pectoris at initial consultation
  • Severe valvular disease
  • Absolute or relative contraindications for Cardiac CT:
  • allergy to iomeron

Lab values

  • LVEF \<45%

Age

  • Age \<30 years or \>75 years

Other

  • Severe COPD or asthma
  • pregnant women, including women who are potentially pregnant or lactating
  • reduced kidney function with an estimated glomerular filtration rate \<40 ml/min

Who the study is looking for

  • Patients with de novo chest pain referred on suspicion of stable ischemic CAD
  • Patients capable of providing written informed consent

Age in the registry: 30 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Regional Hospital of Godstrup
Coordinator of this site? Confirm its status
HerningDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.